Bristol Myers Squibb BMY
NYSE BMY
$67.15 +1.68 (+2.57%)
As of: Aug 21, 2026 · 3:50 PM EDT

Bristol Myers Squibb Co (BMY) Asset Utilization Ratio (2009 - 2026)

Bristol Myers Squibb (BMY) posted quarterly Asset Utilization Ratio of 0.56 for Q2 2026, up 10.8% year-over-year from 0.51 in Q2 2025, and up 2.85% quarter-over-quarter from 0.55 in Q1 2026.

Bristol Myers Squibb Co (BMY) Asset Utilization Ratio (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (BMY) has reported Asset Utilization Ratio for 17 consecutive years, with 0.56 the latest figure, recorded in Q2 2026.

  • In Q2 2026, Asset Utilization Ratio rose 10.8% year-over-year to 0.56; the TTM figure through Jun 2026 stood at 0.56 (up 10.8% YoY), while the FY2025 annual figure was 0.53, up 2.58% from the prior year.
  • Asset Utilization Ratio rose to 0.56 in Q2 2026 per BMY's latest filing, from 0.55 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.56 in Q2 2026 and bottomed at 0.44 in Q1 2022.
  • Historically, Asset Utilization Ratio has averaged 0.49 across 5 years, with a median of 0.48 in 2023.
  • Annual changes were most pronounced in 2022 — Asset Utilization Ratio increased 19.29% — and 2024, when it retreated 2.26%.
  • Bristol Myers Squibb's Asset Utilization Ratio stood at 0.47 in 2022, then climbed by 2.0% to 0.48 in 2023, then climbed by 7.4% to 0.52 in 2024, then slipped by 0.57% to 0.52 in 2025, then rose by 9.57% to 0.56 in 2026.
  • Business Quant data shows BMY's Asset Utilization Ratio at 0.56 in Q2 2026, 0.55 in Q1 2026, and 0.52 in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 0.56
Mar 31, 2026 0.55
Dec 31, 2025 0.52
Sep 30, 2025 0.50
Jun 30, 2025 0.51
Mar 31, 2025 0.51
Dec 31, 2024 0.52
Sep 30, 2024 0.50
Jun 30, 2024 0.48
Mar 31, 2024 0.47
Dec 31, 2023 0.48
Sep 30, 2023 0.49
Jun 30, 2023 0.48
Mar 31, 2023 0.48
Dec 31, 2022 0.47
Sep 30, 2022 0.47
Jun 30, 2022 0.46
Mar 31, 2022 0.44
Dec 31, 2021 0.42
Sep 30, 2021 0.41